Skip to content ↓

MIT releases financials and endowment figures for 2020

Institute’s pooled investments returned 8.3 percent last year; endowment stands at $18.4 billion.

Press Contact:

MIT Media Relations
Phone: 617-253-2700
Close
mit campus shot

The Massachusetts Institute of Technology Investment Management Company (MITIMCo) announced today that MIT’s unitized pool of endowment and other MIT funds generated an investment return of 8.3 percent during the fiscal year ending June 30, 2020, as measured using valuations received within one month of fiscal year end. At the end of the fiscal year, MIT’s endowment funds totaled $18.4 billion, excluding pledges.

MIT’s endowment is intended to support current and future generations of MIT scholars with the resources needed to advance knowledge, research, and innovation. As such, endowment funds are used for Institute activities including education, research, campus renewal, faculty work, and student financial aid.

The Institute’s need-blind undergraduate admissions policy ensures that an MIT education is accessible to all qualified candidates regardless of financial resources. MIT works closely with all families who qualify for financial aid to develop an individual affordability plan tailored to their financial circumstances. In 2019-20, the average MIT scholarship was $49,971. Sixty percent of MIT undergraduates received need-based financial aid, and 38 percent of MIT undergraduate students received scholarship funding from MIT and other sources sufficient to cover the total cost of tuition.

MITIMCo is a unit of MIT, created to manage and oversee the investment of the Institute’s endowment, retirement, and operating funds.

MIT’s Report of the Treasurer for fiscal year 2020 was made available publicly today.

Related Links

Related Topics

Related Articles

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story